Search
Search
Close this search box.

Mark Your Calendar Edition

Circle your calendar for September 27. Join Business of Cannabis for Cannabis + Technology a deep look into the intersection of compliance, transparency, technology and cannabis. Learn more and register today for your Early Bird tickets.

As Canada heads into Legalization 2.0, Business of Cannabis co-founder Jay Rosenthal was featured in Lift&Co. talking about how companies are preparing for the future, “…You are better off producing one thing that you can keep on the shelves, than 30 things you can’t…”

Another week, another CannTrust update. This time, it’s their Vaughn, Ontario facility. This time, like in their greenhouse, the facility was found non-compliant by Health Canada

Some deep dives into Canopy’s recent financials, including this blunt assessment from Marketwatch: Canopy Growth worlds largest pot company lost 1 billion in three months

Speaking of which, Supreme’s CEO had some interesting thoughts about where the industry is vis-a-vis investor appetite, “It’s going to separate good operators from the rest of the pack, because now you’re getting a lot of attention…”

While we’re on public markets and investors, MediPharm Labs graduated from the TSX.v to the TSX this month, rang the bell on Wednesday and joined #BofCLive on Friday. Meet Keith Strachan of MediPharm Labs.

An update about our friends at POPCANN (rewatch the POPCANN interview). The pop up, shipping container-based cannabis shops are getting financing help when located on First Nation land

Coming up this week, a look back on the Top 10 Countdown of #BofCLive Shows You May Have Missed This Summer… Follow along on Twitter.

Do you get this newsletter in your inbox? You should. Here’s how.

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?